Deep clinicopathological phenotyping identifies a previously unrecognized pathogenic EMD splice variant

Authors:

Abstract
Exome sequencing (ES) has revolutionized rare disease management, yet only ˜25%–30% of patients receive a molecular diagnosis. A limiting factor is the quality of available phenotypic data. Here, we describe how deep clinicopathological phenotyping yielded a molecular diagnosis for a 19-year-old proband with muscular dystrophy and negative clinical ES. Deep phenotypic analysis identified two critical data points: (1) the absence of emerin protein in muscle biopsy and (2) clinical features consistent with Emery-Dreifuss muscular dystrophy. Sequencing data analysis uncovered an ultra-rare, intronic variant in EMD, the gene encoding emerin. The variant, NM_000117.3: c.188-6A > G, is predicted to impact splicing by in silico tools. This case thus illustrates how better integration of clinicopathologic data into ES analysis can enhance diagnostic yield with implications for clinical practice.
Funding Information
  • National Institute of Neurological Disorders and Stroke (R35NS105078)
  • Muscular Dystrophy Association (512848, 873841)
  • National Human Genome Research Institute (K08 HG008986, U54HG003273, UM1 HG006542)
  • National Heart, Lung, and Blood Institute (UM1 HG006542)
  • American Academy of Neurology (American Brain Foundation)
  • International Rett Syndrome Foundation (3701‐1)

This publication has 37 references indexed in Scilit: